Development and validation of a radiopathomics model to predict pathological complete response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer: a multicentre observational studyLili Feng, Xiang‐Bo Wan, Fang He et al.|The Lancet Digital Health|2021Cited by 334
Neoadjuvant PD-1 blockade with toripalimab, with or without celecoxib, in mismatch repair-deficient or microsatellite instability-high, locally advanced, colorectal cancer (PICC): a single-centre, parallel-group, non-comparative, randomised, phase 2 trialHuabin Hu, Yanhong Deng, Liang Kang et al.|The Lancet. Gastroenterology & hepatology|2021Cited by 304
Neoadjuvant Chemotherapy With Oxaliplatin and Fluoropyrimidine Versus Upfront Surgery for Locally Advanced Colon Cancer: The Randomized, Phase III OPTICAL TrialHuabin Hu, Yanhong Deng, Jianwei Zhang et al.|Journal of Clinical Oncology|2024Cited by 76
Association of mismatch repair status with survival and response to neoadjuvant chemo(radio)therapy in rectal cancerShubiao Ye, Ping Lan, Yi‐Kan Cheng et al.|npj Precision Oncology|2020Cited by 41
Neoadjuvant Modified Infusional Fluorouracil, Leucovorin, and Oxaliplatin With or Without Radiation Versus Fluorouracil Plus Radiation for Locally Advanced Rectal Cancer: Updated Results of the FOWARC Study After a Median Follow-Up of 10 YearsJianwei Zhang, Yanhong Deng, Pan Chi et al.|Journal of Clinical Oncology|2024Cited by 31